Manufacturing deal wins China cheap supply of GSK's new HIV drug
0
LONDON (Reuters) - China will receive cut-price supplies of GlaxoSmithKline's new HIV drug Tivicay, following a deal for Shanghai-based Desano Pharmaceuticals to become an additional manufacturer of the medicine's active ingredient.